.png?width=300&name=studio%20(1).png)
Venture Studio
.png?width=2000&height=271&name=95626_FY26%20Digital%20Venture%20Studio%20Brand%20Develo%20(1).png)
AccelerOnc Studio is the first venture studio in the United States solely dedicated to oncology innovation. This pioneering initiative is designed to translate the deep clinical, scientific, and technological expertise within health systems (starting with Moffitt Cancer Center) into impactful, scalable solutions for cancer patients worldwide.
AccelerOnc Studio will focus on identifying unmet clinical needs and commercializing intellectual property (IP) generated inside health systems and cancer centers, starting with Moffitt’s own IP. By fostering early-stage ventures rooted in real-world insights from frontline care and research, AccelerOnc aims to radically accelerate the path from innovation to impact in oncology.
Cancer innovation requires unprecedented collaboration. AccelerONC is building an ecosystem where breakthrough ideas become life-changing realities.
